The risk of infection after allo-SCT is determined by the underlying disease, intensity of earlier treatments and by the chosen transplantation modality. High risk of infection even after hematopoietic reconstitution is characteristic compared with patients undergoing conventional chemotherapy or auto-SCT. On account of mucosal damage, functional deficiencies of granulocytes, functional asplenia and qualitative and quantitative T-and B-cell deficiencies, late infections after allo-SCT (after day þ 100 following transplantation) predominate in patients with chronic GVHD. In the absence of GVHD, immunosuppressive treatment is tapered and finally discontinued. In these patients, infectious complications are supposed to occur rarely. We describe a patient who underwent HLAmismatched, unrelated allo-SCT because of bcr-abl-positive ALL and developed severe hepatic abscesses after immunosuppression had been discontinued 1 year earlier.
A 31-year-old patient was transferred to our facility from an outside hospital where he was admitted because of a 2-week history of abdominal discomfort that was accompanied by nausea and emesis. Three days before admission, the patient developed fever up to 39 1C. He also reported a weight loss of 4 kg within the last 3 weeks. The patient had a history of a bcr-abl-positive pre-B-ALL that had been diagnosed in 2004. After induction chemotherapy and one course of chemoconsolidation, he underwent HLA-mismatched, unrelated SCT. His immunosuppression had been tapered and consecutively stopped approximately 1 year before the current admission.
Laboratory analysis revealed an increased serum C-reactive protein (225 mg/l) and serum procalcitonin (3.6 ng/ml). The patient also presented with anemia (hemoglobin 5.7 mmol/l) as well as thrombocytopenia (23 Gpt/l), which, in addition to his complaints, raised concerns for relapsing leukemia. BM aspiration as well as BM biopsy could not detect recurrence of ALL but showed an extended reactive-toxic disintegration of the myelon. The molecular analysis (quantitative real-time PCR) could not detect bcr-abl-mRNA. In the course of further diagnostic procedures, abdominal sonography showed multiple hepatic and splenic round lesions suspicious for abscesses ( Figure 1a) . After puncturing one subcapsular liver lesion, pus was drained. Direct microscopy and cultures of the pus were not sufficient to detect any bacteria, fungus or other infectious pathogens. On the contrary, universal eubacteria PCR was positive. Using direct sequencing analysis, DNA of Yersinia pseudotuberculosis species was detected. The Yersinia Immunoblot IgA, which was serologically applied, confirmed a positive result.
Empirical antibiosis, which had been escalated to meropenem and vancomycin, was stopped and switched instantly to a Yersinia-susceptible medication with ciprofloxacin i.v. and gentamicin i.v. The temperature of the patient decreased until he was afebrile and serum C-reactive protein decreased to 109.5 mg/l. After 7 days with this regimen, the patient again developed fever (maximum temperature of 39.4 1C), elevation of his serum C-reactive protein (maximum at 248 mg/l) and worsening of his clinical status within 24 h. Subsequently, ceftriaxone i.v. was started. The temperature declined and serum C-reactive protein levels returned to normal within a short period of time. Simultaneously, there was gradual resolution of the hepatic and splenic abscesses and improvement of the patient's general condition (Figure 1b ). The patient completed his i.v. antibiosis in an outpatient department and is in remission ever since.
Though relatively rare in humans, infection with Y. pseudotuberculosis is characterized by fever and abdominal pain owing to mesenteric lymphadenitis. 1 Transmission has been reported to have occurred by contact with infected animals, drinking contaminated water or milk as well as eating contaminated food. 2 Fever occurring in a patient later than 100 days after allo-SCT can mostly be attributed to upper and lower respiratory tract infections. 3 In up to 20% of all patients, after day þ 50 of allo-SCT, particularly pneumonias and bacteremias account for the majority of life-threatening infections. 4 Risk factors that increase the possibility of acquisition of zoonoses should be avoided during the first 6 months after transplantation or other significant immunosuppression. 5 Concerning the risk of bacteremias owing to enteric infection, solid organ transplant recipients have higher rates ranging as high as 70% compared with 3-4% in normal hosts and a higher rate of metastatic focus of infection. 6 A recommended periodic assessment of CD4 cell counts or immunoglobulin levels every 3-4 months after transplantation is recommended by some authors. 7 Large-scale retrospective studies have confirmed that the risk of secondary cancers is 3-13 times as high among patients who underwent SCT as among the age-matched control population. 8, 9 However, there exists only one small retrospective study regarding the post transplant immunity in 72 recipients of allogeneic (and autologous) marrow grafts surviving 20 years, and it covered 61% of patientyears by questionnaires. For patients who received transplants as adults, the rate of infection was estimated as 0.09 per year (that is, one infection every 11 years). Interestingly, post-engraftment infections (defined as infections diagnosed between days 30 and 365) in these 'very late survivors' were 18 times higher than the rate at about 20 years after transplantation. 10 This indicates a potential decline of risk of infection over time. Storek et al. 10 also showed that patients after 20 years had normal counts of monocytes, natural killer cells, B cells, CD4 T cells and CD8 T cells. However, the studied population consisted of only transplant recipients younger than 40 years of age. Only limited information can be obtained on the association of specific transplant modalities with late (lifethreatening) infections after allo-SCT in the post-immunosuppression period. As there seems to be a decline of infectious complications over time and as most patients who undergo allo-SCT are enrolled in studies, long-term surveillance to predict patients' individual time of immune reconstitution should be performed. Letter to the Editor
